Real-time enrollment status for this copd clinical trial
Current Status
Terminated
Checked: March 2, 2026 at 12:06 PM UTC
| NCT Number | NCT04636814 |
| Recruiting Status | Terminated |
| Condition | COPD |
| Phase | Clinical Trial |
| Target Enrollment | 3,980 participants |
| Active Locations | 151 sites in the US |
| Sponsor | Chiesi Farmaceutici S.p.A. |
| Last Updated on CT.gov | February 2, 2026 (4 weeks ago) |
As of March 2, 2026: Clinical trial NCT04636814 is currently terminated participants. This clinical trial study for copd is not currently accepting new participants at 151 locations across the United States. The study is sponsored by Chiesi Farmaceutici S.p.A.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04636814 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 151 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04636814 was last updated 4 weeks ago (February 2, 2026). HelloStudys verifies this status automatically.